The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sanger Sequencing Service-Global Market Insights and Sales Trends 2025
Synopsis
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
The global Sanger Sequencing Service market size is expected to reach US$ 212.5 million by 2029, growing at a CAGR of -0.2% from 2023 to 2029. The market is mainly driven by the significant applications of Sanger Sequencing Service in various end use industries. The expanding demands from the Research Institutions, Biotech Companies, Universities and Colleges and Hospitals and Clinics, are propelling Sanger Sequencing Service market. PCR Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasmid DNA segment is estimated at % CAGR for the next seven-year period.
Global Sanger Sequencing Service key players include Thermo Fisher, Eurofins Scientific, and Azenta. The top three producers together hold over 40% of the market share, with Thermo Fisher being the largest producer with 16%. In terms of product categories, PCR products have the largest market share with 44%, followed by plasmid DNA, and in terms of applications, research institutions are the top application area with 28% market share, while biotech companies and universities are also important applications.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sanger Sequencing Service, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sanger Sequencing Service market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sanger Sequencing Service market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sanger Sequencing Service sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sanger Sequencing Service covered in this report include Thermo Fisher, Azenta, Eurofins Scientific, LGC Biosearch Technologies, Fasteris, QuintaraBio, Laragen, Microsynth and Nucleics, etc.
The global Sanger Sequencing Service market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Azenta
Eurofins Scientific
LGC Biosearch Technologies
Fasteris
QuintaraBio
Laragen
Microsynth
Nucleics
GenScript Biotech
CeMIA
StarSEQ
Source BioScience
Guangzhou Life Technologies DaAn
SciGenom Labs
Psomagen
Tsingke Biotechnology
GenHunter
CD Genomics
Shanghai Personalbio Technology
Suzhou Hongxun Biotechnologies
Guangzhou IGE Biotechnology
Global Sanger Sequencing Service market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sanger Sequencing Service market, Segment by Type:
PCR Products
Plasmid DNA
Bacterial Artificial Chromosomes (BAC)
Others
Global Sanger Sequencing Service market, by Application
Research Institutions
Biotech Companies
Universities and Colleges
Hospitals and Clinics
Pharmaceutical Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sanger Sequencing Service companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
The global Sanger Sequencing Service market size is expected to reach US$ 212.5 million by 2029, growing at a CAGR of -0.2% from 2023 to 2029. The market is mainly driven by the significant applications of Sanger Sequencing Service in various end use industries. The expanding demands from the Research Institutions, Biotech Companies, Universities and Colleges and Hospitals and Clinics, are propelling Sanger Sequencing Service market. PCR Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasmid DNA segment is estimated at % CAGR for the next seven-year period.
Global Sanger Sequencing Service key players include Thermo Fisher, Eurofins Scientific, and Azenta. The top three producers together hold over 40% of the market share, with Thermo Fisher being the largest producer with 16%. In terms of product categories, PCR products have the largest market share with 44%, followed by plasmid DNA, and in terms of applications, research institutions are the top application area with 28% market share, while biotech companies and universities are also important applications.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sanger Sequencing Service, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sanger Sequencing Service market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sanger Sequencing Service market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sanger Sequencing Service sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sanger Sequencing Service covered in this report include Thermo Fisher, Azenta, Eurofins Scientific, LGC Biosearch Technologies, Fasteris, QuintaraBio, Laragen, Microsynth and Nucleics, etc.
The global Sanger Sequencing Service market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Azenta
Eurofins Scientific
LGC Biosearch Technologies
Fasteris
QuintaraBio
Laragen
Microsynth
Nucleics
GenScript Biotech
CeMIA
StarSEQ
Source BioScience
Guangzhou Life Technologies DaAn
SciGenom Labs
Psomagen
Tsingke Biotechnology
GenHunter
CD Genomics
Shanghai Personalbio Technology
Suzhou Hongxun Biotechnologies
Guangzhou IGE Biotechnology
Global Sanger Sequencing Service market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sanger Sequencing Service market, Segment by Type:
PCR Products
Plasmid DNA
Bacterial Artificial Chromosomes (BAC)
Others
Global Sanger Sequencing Service market, by Application
Research Institutions
Biotech Companies
Universities and Colleges
Hospitals and Clinics
Pharmaceutical Companies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sanger Sequencing Service companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Sanger Sequencing Service
1.1 Sanger Sequencing Service Market Overview
1.1.1 Sanger Sequencing Service Product Scope
1.1.2 Sanger Sequencing Service Market Status and Outlook
1.2 Global Sanger Sequencing Service Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Sanger Sequencing Service Market Size by Region (2018-2029)
1.4 Global Sanger Sequencing Service Historic Market Size by Region (2018-2023)
1.5 Global Sanger Sequencing Service Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Sanger Sequencing Service Market Size (2018-2029)
1.6.1 North America Sanger Sequencing Service Market Size (2018-2029)
1.6.2 Europe Sanger Sequencing Service Market Size (2018-2029)
1.6.3 Asia-Pacific Sanger Sequencing Service Market Size (2018-2029)
1.6.4 Latin America Sanger Sequencing Service Market Size (2018-2029)
1.6.5 Middle East & Africa Sanger Sequencing Service Market Size (2018-2029)
2 Sanger Sequencing Service Market by Type
2.1 Introduction
2.1.1 PCR Products
2.1.2 Plasmid DNA
2.1.3 Bacterial Artificial Chromosomes (BAC)
2.1.4 Others
2.2 Global Sanger Sequencing Service Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Sanger Sequencing Service Historic Market Size by Type (2018-2023)
2.2.2 Global Sanger Sequencing Service Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Sanger Sequencing Service Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Sanger Sequencing Service Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Sanger Sequencing Service Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Sanger Sequencing Service Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Sanger Sequencing Service Revenue Breakdown by Type (2018-2029)
3 Sanger Sequencing Service Market Overview by Application
3.1 Introduction
3.1.1 Research Institutions
3.1.2 Biotech Companies
3.1.3 Universities and Colleges
3.1.4 Hospitals and Clinics
3.1.5 Pharmaceutical Companies
3.1.6 Others
3.2 Global Sanger Sequencing Service Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Sanger Sequencing Service Historic Market Size by Application (2018-2023)
3.2.2 Global Sanger Sequencing Service Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Sanger Sequencing Service Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Sanger Sequencing Service Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Sanger Sequencing Service Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Sanger Sequencing Service Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Sanger Sequencing Service Revenue Breakdown by Application (2018-2029)
4 Sanger Sequencing Service Competition Analysis by Players
4.1 Global Sanger Sequencing Service Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sanger Sequencing Service as of 2022)
4.3 Date of Key Players Enter into Sanger Sequencing Service Market
4.4 Global Top Players Sanger Sequencing Service Headquarters and Area Served
4.5 Key Players Sanger Sequencing Service Product Solution and Service
4.6 Competitive Status
4.6.1 Sanger Sequencing Service Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher
5.1.1 Thermo Fisher Profile
5.1.2 Thermo Fisher Main Business
5.1.3 Thermo Fisher Sanger Sequencing Service Products, Services and Solutions
5.1.4 Thermo Fisher Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Recent Developments
5.2 Azenta
5.2.1 Azenta Profile
5.2.2 Azenta Main Business
5.2.3 Azenta Sanger Sequencing Service Products, Services and Solutions
5.2.4 Azenta Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.2.5 Azenta Recent Developments
5.3 Eurofins Scientific
5.3.1 Eurofins Scientific Profile
5.3.2 Eurofins Scientific Main Business
5.3.3 Eurofins Scientific Sanger Sequencing Service Products, Services and Solutions
5.3.4 Eurofins Scientific Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.3.5 LGC Biosearch Technologies Recent Developments
5.4 LGC Biosearch Technologies
5.4.1 LGC Biosearch Technologies Profile
5.4.2 LGC Biosearch Technologies Main Business
5.4.3 LGC Biosearch Technologies Sanger Sequencing Service Products, Services and Solutions
5.4.4 LGC Biosearch Technologies Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.4.5 LGC Biosearch Technologies Recent Developments
5.5 Fasteris
5.5.1 Fasteris Profile
5.5.2 Fasteris Main Business
5.5.3 Fasteris Sanger Sequencing Service Products, Services and Solutions
5.5.4 Fasteris Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.5.5 Fasteris Recent Developments
5.6 QuintaraBio
5.6.1 QuintaraBio Profile
5.6.2 QuintaraBio Main Business
5.6.3 QuintaraBio Sanger Sequencing Service Products, Services and Solutions
5.6.4 QuintaraBio Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.6.5 QuintaraBio Recent Developments
5.7 Laragen
5.7.1 Laragen Profile
5.7.2 Laragen Main Business
5.7.3 Laragen Sanger Sequencing Service Products, Services and Solutions
5.7.4 Laragen Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.7.5 Laragen Recent Developments
5.8 Microsynth
5.8.1 Microsynth Profile
5.8.2 Microsynth Main Business
5.8.3 Microsynth Sanger Sequencing Service Products, Services and Solutions
5.8.4 Microsynth Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.8.5 Microsynth Recent Developments
5.9 Nucleics
5.9.1 Nucleics Profile
5.9.2 Nucleics Main Business
5.9.3 Nucleics Sanger Sequencing Service Products, Services and Solutions
5.9.4 Nucleics Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.9.5 Nucleics Recent Developments
5.10 GenScript Biotech
5.10.1 GenScript Biotech Profile
5.10.2 GenScript Biotech Main Business
5.10.3 GenScript Biotech Sanger Sequencing Service Products, Services and Solutions
5.10.4 GenScript Biotech Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.10.5 GenScript Biotech Recent Developments
5.11 CeMIA
5.11.1 CeMIA Profile
5.11.2 CeMIA Main Business
5.11.3 CeMIA Sanger Sequencing Service Products, Services and Solutions
5.11.4 CeMIA Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.11.5 CeMIA Recent Developments
5.12 StarSEQ
5.12.1 StarSEQ Profile
5.12.2 StarSEQ Main Business
5.12.3 StarSEQ Sanger Sequencing Service Products, Services and Solutions
5.12.4 StarSEQ Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.12.5 StarSEQ Recent Developments
5.13 Source BioScience
5.13.1 Source BioScience Profile
5.13.2 Source BioScience Main Business
5.13.3 Source BioScience Sanger Sequencing Service Products, Services and Solutions
5.13.4 Source BioScience Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.13.5 Source BioScience Recent Developments
5.14 Guangzhou Life Technologies DaAn
5.14.1 Guangzhou Life Technologies DaAn Profile
5.14.2 Guangzhou Life Technologies DaAn Main Business
5.14.3 Guangzhou Life Technologies DaAn Sanger Sequencing Service Products, Services and Solutions
5.14.4 Guangzhou Life Technologies DaAn Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.14.5 Guangzhou Life Technologies DaAn Recent Developments
5.15 SciGenom Labs
5.15.1 SciGenom Labs Profile
5.15.2 SciGenom Labs Main Business
5.15.3 SciGenom Labs Sanger Sequencing Service Products, Services and Solutions
5.15.4 SciGenom Labs Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.15.5 SciGenom Labs Recent Developments
5.16 Psomagen
5.16.1 Psomagen Profile
5.16.2 Psomagen Main Business
5.16.3 Psomagen Sanger Sequencing Service Products, Services and Solutions
5.16.4 Psomagen Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.16.5 Psomagen Recent Developments
5.17 Tsingke Biotechnology
5.17.1 Tsingke Biotechnology Profile
5.17.2 Tsingke Biotechnology Main Business
5.17.3 Tsingke Biotechnology Sanger Sequencing Service Products, Services and Solutions
5.17.4 Tsingke Biotechnology Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.17.5 Tsingke Biotechnology Recent Developments
5.18 GenHunter
5.18.1 GenHunter Profile
5.18.2 GenHunter Main Business
5.18.3 GenHunter Sanger Sequencing Service Products, Services and Solutions
5.18.4 GenHunter Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.18.5 GenHunter Recent Developments
5.19 CD Genomics
5.19.1 CD Genomics Profile
5.19.2 CD Genomics Main Business
5.19.3 CD Genomics Sanger Sequencing Service Products, Services and Solutions
5.19.4 CD Genomics Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.19.5 CD Genomics Recent Developments
5.20 Shanghai Personalbio Technology
5.20.1 Shanghai Personalbio Technology Profile
5.20.2 Shanghai Personalbio Technology Main Business
5.20.3 Shanghai Personalbio Technology Sanger Sequencing Service Products, Services and Solutions
5.20.4 Shanghai Personalbio Technology Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.20.5 Shanghai Personalbio Technology Recent Developments
5.21 Suzhou Hongxun Biotechnologies
5.21.1 Suzhou Hongxun Biotechnologies Profile
5.21.2 Suzhou Hongxun Biotechnologies Main Business
5.21.3 Suzhou Hongxun Biotechnologies Sanger Sequencing Service Products, Services and Solutions
5.21.4 Suzhou Hongxun Biotechnologies Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.21.5 Suzhou Hongxun Biotechnologies Recent Developments
5.22 Guangzhou IGE Biotechnology
5.22.1 Guangzhou IGE Biotechnology Profile
5.22.2 Guangzhou IGE Biotechnology Main Business
5.22.3 Guangzhou IGE Biotechnology Sanger Sequencing Service Products, Services and Solutions
5.22.4 Guangzhou IGE Biotechnology Sanger Sequencing Service Revenue (US$ Million) & (2018-2023)
5.22.5 Guangzhou IGE Biotechnology Recent Developments
6 North America
6.1 North America Sanger Sequencing Service Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Sanger Sequencing Service Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sanger Sequencing Service Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sanger Sequencing Service Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sanger Sequencing Service Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sanger Sequencing Service Market Dynamics
11.1 Sanger Sequencing Service Industry Trends
11.2 Sanger Sequencing Service Market Drivers
11.3 Sanger Sequencing Service Market Challenges
11.4 Sanger Sequencing Service Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
